| Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma MM Kamel, M Matboli, M Sallam, IF Montasser, AS Saad, AHF El-Tawdi Translational Research 168, 134-145, 2016 | 138 | 2016 |
| Metformin addition to chemotherapy in stage IV non-small cell lung cancer: an open label randomized controlled study R Sayed, AS Saad, L El Wakeel, E Elkholy, O Badary Asian Pacific Journal of Cancer Prevention 16 (15), 6621-6626, 2015 | 67 | 2015 |
| L-Carnosine protects against Oxaliplatin-induced peripheral neuropathy in colorectal cancer patients: A perspective on targeting Nrf-2 and NF-κB pathways R Yehia, S Saleh, H El Abhar, AS Saad, M Schaalan Toxicology and applied pharmacology 365, 41-50, 2019 | 60 | 2019 |
| Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial P Merle, JF Blanc, JM Phelip, G Pelletier, JP Bronowicki, Y Touchefeu, ... The Lancet Gastroenterology & Hepatology 4 (6), 454-465, 2019 | 47 | 2019 |
| Pentoxifylline and vitamin E reduce the severity of radiotherapy-induced oral mucositis and dysphagia in head and neck cancer patients: a randomized, controlled study R Sayed, L El Wakeel, AS Saad, M Kelany, M El-Hamamsy Medical Oncology 37 (1), 8, 2020 | 30 | 2020 |
| A randomized controlled open-label pilot study of simvastatin addition to whole-brain radiation therapy in patients with brain metastases M El-Hamamsy, H Elwakil, AS Saad, MA Shawki Oncology research 24 (6), 521, 2016 | 21 | 2016 |
| P05.02 Chemotherapy-induced peripheral neuropathy in Egyptian patients: single institution retrospective analysis AGKEASM Ashraf Neuro Oncol 19 (suppl_3), iii47, 2017 | 13* | 2017 |
| A prospective randomized controlled study of cisplatin versus carboplatin-based regimen in advanced squamous nonsmall cell lung cancer AS Saad, RR Ghali, MA Shawki Journal of cancer research and therapeutics 13 (2), 198-203, 2017 | 12 | 2017 |
| FAS and FASL genetic polymorphisms impact on clinical outcome of malignant pleural mesothelioma M El-Hamamsy, RR Ghali, AS Saad, SM Shaheen, AM Salem OncoTargets and therapy, 6857-6863, 2016 | 12 | 2016 |
| Insights into the prognostic value of DJ-1 and MIB-1 in astrocytic tumors RM Abd El Atti, HH Abou Gabal, WM Osman, AS Saad Diagnostic Pathology 8, 1-9, 2013 | 12 | 2013 |
| The effect of itraconazole on the clinical outcomes of patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a randomized controlled study AW Mohamed, M Elbassiouny, DA Elkhodary, MA Shawki, AS Saad Medical Oncology 38, 1-9, 2021 | 11 | 2021 |
| The Association Between the FTO rs9939609 Variant and Malignant Pleural Mesothelioma Risk: A Case–Control Study MS Khella, AM Salem, O Abdel-Rahman, AS Saad Genetic Testing and Molecular Biomarkers 22 (2), 79-84, 2018 | 11 | 2018 |
| Prognostic utility of lncRNAs (LINC00565 and LINC00641) as molecular markers in glioblastoma multiforme (GBM) RG Amer, LR Ezz El Arab, D Abd El Ghany, AS Saad, N Bahie-Eldin, ... Journal of Neuro-oncology 158 (3), 435-444, 2022 | 7 | 2022 |
| An open-label randomized controlled phase II study of clarithromycin (CL) plus CVP in patients (pts) with previously untreated stage III/IV indolent non Hodgkin lymphoma (NHL). AS Saad, SM Shaheen, MH Elhamamsy, OA Badary Journal of Clinical Oncology 32 (15_suppl), e19510-e19510, 2014 | 7 | 2014 |
| Impact of TNF-α gene polymorphisms on pancreatic and non-small cell lung cancer-induced cachexia in adult Egyptian patients: a focus on pathogenic trajectories R Yehia, M Schaalan, DM Abdallah, AS Saad, N Sarhan, S Saleh Frontiers in Oncology 11, 783231, 2021 | 6 | 2021 |
| Lancet Gastroenterol P Merle, JF Blanc, JM Phelip, G Pelletier, JP Bronowicki, Y Touchefeu, ... Hepatol 4, 454, 2019 | 5 | 2019 |
| A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in Egypt B Elezbawy, AN Fasseeh, A Sedrak, R Eldessouki, M Gamal, M Eldebeiky, ... Journal of Pharmaceutical Policy and Practice 15 (1), 10, 2022 | 4 | 2022 |
| Evaluation of the clinical effect of pharmacist intervention: Results of patient education about breast cancer DK Farrag, NA Sabri, AS Tawfik, SM Shaheen European Journal of Oncology Pharmacy 3 (1), e23, 2020 | 4 | 2020 |
| Prediction of chemotherapy prescribing errors for oncology patients HE Barakat, NA Sabri, AS Saad International Journal of Pharmaceutical Sciences and Research 7 (8), 3274, 2016 | 4 | 2016 |
| Prognostic impact of MYD88 and TP53 mutations in diffuse large B Cell lymphoma OAEH Ebid, LR Ezz El Arab, AS Saad, M Ezz El Din, N Mostafa, ... Annals of Hematology 102 (12), 3477-3488, 2023 | 3 | 2023 |
